Literature DB >> 22308531

Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus.

Carolina Llanos1, Deborah M Friedman, Amit Saxena, Peter M Izmirly, Chung-E Tseng, Renata Dische, Rosanna G Abellar, Marc Halushka, Robert M Clancy, Jill P Buyon.   

Abstract

OBJECTIVE: The autopsy and clinical information on children dying with anti-SSA/Ro-associated cardiac manifestations of neonatal lupus (cardiac NL) were examined to identify patterns of disease, gain insight into pathogenesis and enhance the search for biomarkers and preventive therapies.
METHODS: A retrospective analysis evaluating reports from 18 autopsies of cardiac NL cases and clinical data from the Research Registry for Neonatal Lupus was performed.
RESULTS: Of the 18 cases with autopsies, 15 had advanced heart block, including 3 who died in the second trimester, 9 in the third trimester and 3 post-natally. Three others died of cardiomyopathy without advanced block, including two dying pre-natally and one after birth. Pathological findings included fibrosis/calcification of the atrioventricular (AV) node, sinoatrial (SA) node and bundle of His, endocardial fibroelastosis (EFE), papillary muscle fibrosis, valvular disease, calcification of the atrial septum and mononuclear pancarditis. There was no association of pathology with the timing of death except that in the third-trimester deaths more valvular disease and/or extensive conduction system abnormalities were observed. Clinical rhythm did not always correlate with pathology of the conduction system, and the pre-mortem echocardiograms did not consistently detect the extent of pathology.
CONCLUSION: Fibrosis of the AV node/distal conduction system is the most characteristic histopathological finding. Fibrosis of the SA node and bundle of His, EFE and valve damage are also part of the anti-Ro spectrum of injury. Discordance between echocardiograms and pathology findings should prompt the search for more sensitive methods to accurately study the phenotype of antibody damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308531      PMCID: PMC3354677          DOI: 10.1093/rheumatology/ker515

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  30 in total

Review 1.  Genesis and regulation of the heart automaticity.

Authors:  Matteo E Mangoni; Joël Nargeot
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

2.  Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.

Authors:  Robert M Clancy; Jill P Buyon; Keigo Ikeda; Kazuhisa Nozawa; Dionne A Argyle; Deborah M Friedman; Edward K L Chan
Journal:  Arthritis Rheum       Date:  2005-10

3.  Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.

Authors:  Robert M Clancy; Petra J Neufing; Ping Zheng; Marguerita O'Mahony; Falk Nimmerjahn; Tom P Gordon; Jill P Buyon
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

4.  Antibody reactivity to alpha-enolase in mothers of children with congenital heart block.

Authors:  Carolina Llanos; Edward K L Chan; Songqing Li; Grant X Abadal; Peter Izmirly; Caroline Byrne; Robert M Clancy; Jill P Buyon
Journal:  J Rheumatol       Date:  2009-02-04       Impact factor: 4.666

5.  Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block.

Authors:  Robert M Clancy; Raj P Kapur; Yair Molad; Anca Dinu Askanase; Jill P Buyon
Journal:  Arthritis Rheum       Date:  2004-01

6.  Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus.

Authors:  T L Rivera; P M Izmirly; B K Birnbaum; P Byrne; J B Brauth; M Katholi; M Y Kim; J Fischer; R M Clancy; J P Buyon
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

7.  Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.

Authors:  Deborah M Friedman; Mimi Y Kim; Joshua A Copel; Claudine Davis; Colin K L Phoon; Julie S Glickstein; Jill P Buyon
Journal:  Circulation       Date:  2008-01-14       Impact factor: 29.690

8.  Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.

Authors:  Carolina Llanos; Peter M Izmirly; Margaret Katholi; Robert M Clancy; Deborah M Friedman; Mimi Y Kim; Jill P Buyon
Journal:  Arthritis Rheum       Date:  2009-10

9.  An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac disease.

Authors:  Bettina F Cuneo; Janette F Strasburger; Alisa Niksch; Marc Ovadia; Ronald T Wakai
Journal:  J Matern Fetal Neonatal Med       Date:  2009-03

Review 10.  Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside.

Authors:  Jill P Buyon; Robert M Clancy; Deborah M Friedman
Journal:  Nat Clin Pract Rheumatol       Date:  2009-03
View more
  24 in total

1.  Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block.

Authors:  Robert M Clancy; Marc Halushka; Sara E Rasmussen; Tenzin Lhakhang; Miao Chang; Jill P Buyon
Journal:  J Immunol       Date:  2018-12-05       Impact factor: 5.422

2.  Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Authors:  Amit Saxena; Peter M Izmirly; Sung Won Han; Paraskevi Briassouli; Tania L Rivera; Hua Zhong; Deborah M Friedman; Robert M Clancy; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

Review 3.  Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.

Authors:  Peter Izmirly; Amit Saxena; Jill P Buyon
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

4.  Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block.

Authors:  Robert M Clancy; Androo J Markham; Tanisha Jackson; Sara E Rasmussen; Miroslav Blumenberg; Jill P Buyon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

5.  Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.

Authors:  Robert M Clancy; Androo J Markham; Joanne H Reed; Miroslav Blumenberg; Marc K Halushka; Jill P Buyon
Journal:  J Autoimmun       Date:  2015-10-01       Impact factor: 7.094

6.  No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine.

Authors:  Deborah Friedman; Leif Lovig; Marc Halushka; Robert M Clancy; Peter M Izmirly; Jill P Buyon
Journal:  Clin Exp Rheumatol       Date:  2017-06-06       Impact factor: 4.473

7.  Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Authors:  Hannah C Ainsworth; Miranda C Marion; Tiziana Bertero; Antonio Brucato; Rolando Cimaz; Nathalie Costedoat-Chalumeau; Micaela Fredi; Patrick Gaffney; Jennifer Kelly; Kateri Levesque; Alice Maltret; Nathalie Morel; Veronique Ramoni; Amelia Ruffatti; Carl D Langefeld; Jill P Buyon; Robert M Clancy
Journal:  Arthritis Rheumatol       Date:  2017-10-17       Impact factor: 10.995

Review 8.  The clinical spectrum of autoimmune congenital heart block.

Authors:  Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

9.  A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies.

Authors:  Paraskevi Briassouli; Marc K Halushka; Joanne H Reed; Yair Molad; Karen Fox-Talbot; Lucas Buyon; Edwin Guzman; Achiau Ludomirsky; Robert M Clancy; Jill P Buyon
Journal:  Rheumatology (Oxford)       Date:  2013-04-18       Impact factor: 7.580

10.  Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.

Authors:  Peter Izmirly; Mimi Kim; Deborah M Friedman; Nathalie Costedoat-Chalumeau; Robert Clancy; Joshua A Copel; Colin K L Phoon; Bettina F Cuneo; Rebecca E Cohen; Kimberly Robins; Mala Masson; Benjamin J Wainwright; Noel Zahr; Amit Saxena; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2020-07-21       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.